BAGNOL CONSULTING provides expertise in preclinical drug discovery through onsite training, study evaluation and validation.
• Target identification and validation in various tissues and therapeutic areas.
• Projects evaluation and target portfolio management.
• In vivo pharmacology assays development, translational disease models validation for proof of concept or mechanism of action studies.
• Histology and tissues processing, immunohistochemistry, in situ hybridization, single labeling or multiplexing for cellular expression studies, determination of biological pathways and mechanistic hypothesis generation. Digital microscopy analysis.
• Autoradiography and biomarker ID for receptor occupancy and/or target engagement studies.
• Human biological specimen’s procurement, processing for reverse translational studies. Human and rodent neuroanatomy.
• CROs and external collaborations management.
• Business development, in-licensing opportunities sourcing and evaluation, competitive intelligence and partnership support.
Didier Bagnol is a Ph.D. level scientist with training in neuroscience and physiology with 20 year’s R&D expertise in the pharmaceutical industry and academia. From February 2001 to August 2016, Dr Bagnol was a research director at Arena Pharmaceuticals Inc. - a biopharmaceutical company based in US, specialized in small molecule drug discovery for G protein-coupled receptors. Dr Bagnol initiated and led several preclinical drug discovery programs from idea generation to late lead compound identification and participated in the nomination of several clinical candidates which led to IND filing one of which was approved by the FDA in 2012. Didier’s effort in establishing and managing cellular imaging and histology research core laboratories was instrumental for the identification of novel and innovative drug targets. He developed proven abilities to set up in vivo pharmacology and translational animal models for target validation, lead compound identification and optimization, proof of principle and mechanism of action studies. Through these various activities Didier has gained broad expertise across all phases of drug discovery and early development in various therapeutic areas such as neuroscience, endocrinology, metabolic diseases, diabetes, gastroenterology and inflammation. During his tenure at Arena, Didier participation helped to establish the success of numerous partnerships with pharmaceuticals companies like Eli-Lilly, Johnson & Johnson, Boerhinger-Ingelheim. He established and managed critical external collaborations with leading team in academia or carefully selected contract research organizations with relevant expertise. Prior to join Arena, Didier was a tenured Associate Professor at Aix-Marseille University, France and a research fellow at the Molecular and behavioral Neuroscience Institute, University of Michigan, Medical School, Ann Arbor. He authored numerous peer review publications and is an inventor on several patents.
Publications
I provide on site expertise for in vivo pharmacology, PK/PD studies and tissue necropsy. I can develop translational in vivo pharmacology assays in various therapeutic areas such as CNS (Neurology, psychiatric diseases,...), metabolic disorders, diabetes, gastroenterology, neuroendocrinology, immunology.
I can section any type of tissues from you can provide from small animals to human, fresh frozen or formalin-fixed paraffin embedded. Paraffin embedding could be generated on formalin-fixed samples...
I provide expertise in histology and tissues processing (rodent or human tissues samples if available), specialized in Neuroanatomy, immunohistochemistry, in situ hybridization, target engagement. I can provide this independently or on site with training.
I can perform autoradiography studies for receptor occupancy studies or binding studies, on site only with radioactive licence. This approach could be used for PET ligand validation.
Mouse diet induced obese models, Type 1 diabetes. CNS models: neurodegenerative diseases, motor disorders, neuropsychiatric diseases...
I can evaluate projects, targets and new in-licensing opportunities. I can also perform competitive intelligence evaluation.
I provide expertise in histology and tissues processing (rodent or human tissues samples if available), specialized in Neuroanatomy, immunohistochemistry, in situ hybridization, target engagement. I can provide this independently or on site with training.
BAGNOL CONSULTING has not received any reviews.
BAGNOL CONSULTING has not received any endorsements.